VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,415,924 | -57.9% | 52,617 | -52.9% | 0.00% | -66.7% |
| Q2 2023 | $3,362,955 | -3.5% | 111,689 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $3,483,739 | +10.1% | 107,689 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $3,164,466 | +34.1% | 110,414 | +12.8% | 0.00% | +50.0% |
| Q3 2022 | $2,360,000 | +114.0% | 97,868 | +143.0% | 0.00% | +100.0% |
| Q2 2022 | $1,103,000 | -26.4% | 40,267 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,498,000 | +16.3% | 39,064 | -2.9% | 0.00% | 0.0% |
| Q4 2021 | $1,288,000 | +16.5% | 40,239 | +7.1% | 0.00% | 0.0% |
| Q3 2021 | $1,106,000 | -21.9% | 37,556 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $1,416,000 | +4.5% | 41,702 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,355,000 | -52.6% | 41,702 | -47.4% | 0.00% | -66.7% |
| Q4 2020 | $2,857,000 | +56.7% | 79,296 | +70.4% | 0.00% | +50.0% |
| Q3 2020 | $1,823,000 | +13.6% | 46,546 | +6.3% | 0.00% | 0.0% |
| Q2 2020 | $1,605,000 | +70.9% | 43,782 | +7.3% | 0.00% | +100.0% |
| Q1 2020 | $939,000 | -25.9% | 40,800 | -5.7% | 0.00% | 0.0% |
| Q4 2019 | $1,268,000 | +8.5% | 43,280 | -1.1% | 0.00% | 0.0% |
| Q3 2019 | $1,169,000 | +33.8% | 43,751 | +28.0% | 0.00% | 0.0% |
| Q2 2019 | $874,000 | +14.1% | 34,170 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $766,000 | -3.6% | 34,230 | -9.3% | 0.00% | 0.0% |
| Q4 2018 | $795,000 | +30.5% | 37,730 | +14.7% | 0.00% | 0.0% |
| Q3 2018 | $609,000 | -17.3% | 32,883 | -0.4% | 0.00% | 0.0% |
| Q2 2018 | $736,000 | +1.4% | 33,030 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $726,000 | -12.9% | 33,030 | -7.9% | 0.00% | 0.0% |
| Q4 2017 | $834,000 | -1.2% | 35,880 | -2.4% | 0.00% | 0.0% |
| Q3 2017 | $844,000 | +3.7% | 36,759 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $814,000 | 0.0% | 36,909 | +3.4% | 0.00% | 0.0% |
| Q1 2017 | $814,000 | +22.8% | 35,709 | +12.9% | 0.00% | 0.0% |
| Q4 2016 | $663,000 | -14.0% | 31,641 | +8.4% | 0.00% | 0.0% |
| Q3 2016 | $771,000 | +35.7% | 29,179 | +42.1% | 0.00% | 0.0% |
| Q2 2016 | $568,000 | – | 20,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |